Long-acting amylin analog studied in energy-balance models.
For research use only. Not for human or veterinary use. No claims of safety, efficacy or therapeutic benefit.
Amylin-related satiety signaling and energy balance; greater weight reduction than placebo in a phase 2 trial in adults with overweight or obesity. Gastrointestinal effects and injection-site reactions were reported.
Clinical findings apply to the studied formulation, population and indication. They do not establish equivalence, safety or therapeutic efficacy of this research product.
PMID: 34798060
Contact the Avitus team to confirm available presentations, product specifications and pricing for your research requirements.